Shree Ganesh Remedies P/E Ratio

SGRL • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
33.13
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 33.13
Current Price ₹420.05
EPS (TTM) ₹17.96
Exchange BSE

Valuation Signal

Signal Overvalued
Historical Avg 27.58
Historical Range 22.01 - 32.9
Percentile 100.0%

Sector Context

Sector Average 47.33
Sector Median 25.62
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹14.08
Sept 2025 ₹3.86
Mar 2025 ₹5.13

Key P/E Ratio Insights for Shree Ganesh Remedies

  • Stock appears overvalued with PE of 33.13, suggesting caution for new investments
  • Current PE is 20.1% above historical average
  • Trading at discount to sector average PE of 47.33

P/E Ratio Historical Trend for Shree Ganesh Remedies

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 32.9 14.08 ₹463.20 BSE High
2024 27.82 22.82 ₹634.80 BSE High
2021 22.01 14.23 ₹313.20 BSE Moderate

Sector P/E Ratio Comparison

Comparing Shree Ganesh Remedies with other companies in Healthcare sector
Sector Average
47.33
Sector Median
25.62
Lowest P/E
0.9
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.9 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.48 ₹1,128 Low
Amwill Health Care AMWILL 5.98 ₹61 Low
Medicamen Organics MEDIORG 6.37 ₹25 Low
Brooks Laboratories BROOKS 6.41 ₹127 Low
Unichem Laboratories UNICHEMLAB 7.14 ₹2,000 Low
Zenith Drugs ZENITHDRUG 7.28 ₹65 Low
Galaxy Medicare GML 7.77 ₹26 Low
Vasundhara Rasayans VRL 9.19 ₹34 Low